loadpatents
Patent applications and USPTO patent grants for ABRAMS; Tinya.The latest application filed is for "pharmaceutical combination comprising lsz102 and ribociclib".
Patent | Date |
---|---|
Pharmaceutical Combination Comprising Lsz102 And Ribociclib App 20220031657 - ABRAMS; Tinya ;   et al. | 2022-02-03 |
Pharmaceutical combination comprising LSZ102 and ribociclib Grant 11,179,365 - Abrams , et al. November 23, 2 | 2021-11-23 |
Pharmaceutical Combination Comprising Lsz102 And Alpelisib App 20210000810 - Abrams; Tinya ;   et al. | 2021-01-07 |
Ckit Antibody Drug Conjugates App 20200405875 - ABRAMS; Tinya ;   et al. | 2020-12-31 |
CKIT antibody drug conjugates Grant 10,786,578 - Abrams , et al. September 29, 2 | 2020-09-29 |
Pharmaceutical combination comprising LSZ102 and alpelisib Grant 10,695,333 - Abrams , et al. | 2020-06-30 |
Antibody Drug Conjugates App 20200129632 - ABRAMS; Tinya ;   et al. | 2020-04-30 |
Antibody drug conjugates Grant 10,626,172 - Abrams , et al. | 2020-04-21 |
Antibody Drug Conjugates App 20190194315 - ABRAMS; Tinya ;   et al. | 2019-06-27 |
Pharmaceutical Combination Comprising Lsz102 And Alpelisib App 20190167652 - ABRAMS; Tinya ;   et al. | 2019-06-06 |
Pharmaceutical Combination Comprising Lsz102 And Ribociclib App 20190142796 - ABRAMS; Tinya ;   et al. | 2019-05-16 |
Antibody Drug Conjugates App 20190119375 - Abrams; Tinya ;   et al. | 2019-04-25 |
Antibody drug conjugates Grant 10,117,953 - Abrams , et al. November 6, 2 | 2018-11-06 |
Ckit Antibody Drug Conjugates App 20180193475 - ABRAMS; Tinya ;   et al. | 2018-07-12 |
Antibody drug conjugates Grant 10,005,836 - Abrams , et al. June 26, 2 | 2018-06-26 |
Antibody Drug Conjugates App 20180125996 - ABRAMS; Tinya ;   et al. | 2018-05-10 |
cKIT antibody drug conjugates Grant 9,789,203 - Abrams , et al. October 17, 2 | 2017-10-17 |
Antibody Drug Conjugates App 20170035905 - Abrams; Tinya ;   et al. | 2017-02-09 |
Antibody drug conjugates Grant 9,498,543 - Abrams , et al. November 22, 2 | 2016-11-22 |
Antibody Drug Conjugates App 20160137730 - ABRAMS; Tinya ;   et al. | 2016-05-19 |
Antibody Drug Conjugates App 20160030594 - ABRAMS; Tinya ;   et al. | 2016-02-04 |
Antibody Drug Conjugates App 20150320880 - ABRAMS; Tinya ;   et al. | 2015-11-12 |
Antibody Drug Conjugates App 20140271688 - Abrams; Tinya ;   et al. | 2014-09-18 |
Substituted imidazole derivates Grant 8,735,599 - Wang , et al. May 27, 2 | 2014-05-27 |
Kinesin inhibitors as cancer therapeutics Grant 8,664,256 - Abrams , et al. March 4, 2 | 2014-03-04 |
Triazole Compounds As Ksp Inhibitors App 20140056880 - Abrams; Tinya ;   et al. | 2014-02-27 |
Triazole compounds as KSP inhibitors Grant 8,546,434 - Abrams , et al. October 1, 2 | 2013-10-01 |
Substituted Imidazole Derivatives App 20130017196 - Wang; Weibo ;   et al. | 2013-01-17 |
Kinesin Inhibitors As Cancer Therapeutics App 20130012560 - Abrams; Tinya ;   et al. | 2013-01-10 |
Substituted imidazole derivatives Grant 8,318,791 - Wang , et al. November 27, 2 | 2012-11-27 |
Kinesin inhibitors as cancer therapeutics Grant 8,252,832 - Abrams , et al. August 28, 2 | 2012-08-28 |
Triazole Compounds As Ksp Inhibitors App 20110256128 - ABRAMS; Tinya ;   et al. | 2011-10-20 |
Substituted imidazole derivatives App 20090258016 - Wang; Weibo ;   et al. | 2009-10-15 |
Kinesin inhibitors as cancer therapeutics App 20090239922 - Abrams; Tinya ;   et al. | 2009-09-24 |
Substituted imidazole derivatives Grant 7,576,221 - Wang , et al. August 18, 2 | 2009-08-18 |
Substituted imidazole derivatives App 20060009472 - Wang; Weibo ;   et al. | 2006-01-12 |
Treatment of excessive osteolysis with indolinone compounds App 20040209937 - Murray, Lesley ;   et al. | 2004-10-21 |
Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders App 20040152759 - Abrams, Tinya ;   et al. | 2004-08-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.